Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 125.16
-3.32 (-2.58%)
Apr 29, 2025, 2:45 PM CST
Beijing Hotgen Biotech Revenue
In the year 2024, Beijing Hotgen Biotech had annual revenue of 510.89M CNY, down -5.61%. Beijing Hotgen Biotech had revenue of 124.73M in the quarter ending December 31, 2024, a decrease of -7.15%.
Revenue
510.89M
Revenue Growth
-5.61%
P/S Ratio
22.53
Revenue / Employee
n/a
Employees
1,036
Market Cap
11.51B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |